|
1
|
A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1.
|
AIDS
|
2006
|
1.33
|
|
2
|
Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort.
|
BMC Public Health
|
2010
|
1.18
|
|
3
|
A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals.
|
J Hepatol
|
2010
|
1.02
|
|
4
|
Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load.
|
J Infect Dis
|
2006
|
0.95
|
|
5
|
Evaluation in macaques of HIV-1 DNA vaccines containing primate CpG motifs and fowlpoxvirus vaccines co-expressing IFNgamma or IL-12.
|
Vaccine
|
2004
|
0.90
|
|
6
|
Heterosubtypic T-cell responses against avian influenza H5 haemagglutinin are frequently detected in individuals vaccinated against or previously infected with human subtypes of influenza.
|
Influenza Other Respir Viruses
|
2008
|
0.86
|
|
7
|
Clearance of hepatitis C virus and T cell response in a child with anti-liver kidney microsomal-1 antibodies treated with steroids.
|
J Paediatr Child Health
|
2010
|
0.75
|